A Phase III study of Solithromycin in patients with sinusitis
Phase 3
- Conditions
- Sinusitis
- Registration Number
- JPRN-jRCT2080223677
- Lead Sponsor
- Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Age: 20 years of age and older (at the time of obtaining informed consents)
2.Gender : Both
3.Inpatient/Outpatient status: Outpatient
4.Signed the informed consent form by patients
5.Sinusitis with clear infection symptoms
Exclusion Criteria
1.Having improvement of clinical symptoms due to target disease by other systemic antibiotics
2.Having a history of allergy to macrolide, penicillin or cephem antibiotics
3.Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method